General MedicationsORALGeneric
IBUPROFEN
IBUPROFEN
Standard Dose
50MG/1.25ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: UNKNOWN Marketing status: Discontinued
Summary
Approval overview IBUPROFEN is listed in Drugs@FDA under application 214071 (ANDA).
Review priority: UNKNOWN Marketing status: Discontinued Active ingredient IBUPROFEN Form and strength SUSPENSION/DROPS;ORAL - 50MG/1.25ML Sponsor STRIDES PHARMA Submission history Latest submission status date: 2023-03-27 00:00:00.
Structured Monograph
Clinical summary
Approval overview IBUPROFEN is listed in Drugs@FDA under application 214071 (ANDA). Review priority: UNKNOWN Marketing status: Discontinued Active ingredient IBUPROFEN Form and strength SUSPENSION/DROPS;ORAL - 50MG/1.25ML Sponsor STRIDES PHARMA Submission history Latest submission status date: 2023-03-27 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: UNKNOWN
Interaction Notes
- No interaction notes stored yet.